Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Oct 22, 2010


Thermo Fisher Scientific announced this week the formation of a scientific advisory board intended to formalize its interaction with leading research centers around the world.

The newly formed board includes Thermo Fisher board member and Massachusetts Institute of Technology biology professor Tyler Jacks; Ronald Davis of Stanford University's department of biochemistry; Steven Gygi of Harvard Medical School's department of cell biology; William Hahn of Dana-Farber Cancer Institute's department of medical oncology; and David Hillyard of the University of Utah's department of pathology.

Pierre Meulien was appointed this week president and CEO of Genome Canada.

Meulien will be stepping down from his role as chief scientific officer of Genome BC to take the new position. Previously he worked as senior vice president of R&D and director of research at Aventis Pasteur.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.